Prognosis After Discontinuation of Azathioprine or Mycophenolate Mofetil in Well‐Controlled Myasthenia Gravis: A Retrospective Analysis
The results of this study suggest that patients in PR are less likely to relapse compared to those in MM 1. In well-controlled MG patients, AZA/MMF may be discontinued.
Authors
- İnci Şule Özer (ORCID: https://orcid.org/0000-0001-7051-8516)
- İhsan Şükrü Şengün (ORCID: https://orcid.org/0000-0003-1877-8892)
- Ergi Kaya (ORCID: https://orcid.org/0000-0001-9003-7066)
- Ahmet Yusuf Ertürk (ORCID: https://orcid.org/0000-0002-1025-0519)
Institutions
- Dokuz Eylül University (TR)
Publication Details
- Journal
- Muscle & Nerve
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1002/mus.70105
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00